Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > GI Drugs > Flashcards

GI Drugs Flashcards

1
Q

Regulation of gastric acid secretion

A

Histamine (endocrine)

- H2 receptor coupled to Gs 
- Increased cAMP in parietal cell 
- Protein kinases upregulate activity of proton pump --> pumps acid into gastric lumen

Ach (neural via vagus nerve)

- M3 coupled to Gq 
- Increased intracellular Ca2+ 
- Increased activity of proton pump

Gastrin (paracrine)

- Does not use a gastrin receptor 
- Uses CCKb receptor, results in increase in intracellular Ca2+

Prostaglandin E2

- Coupled to Gi 
- Inhibitory activity --> decreased AC and cAMP and downregulates the proton pump 
- Has a protective activity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antacids MOA

A

Weak bases

Act as chemical antagonist –> neutralisation reaction with acid to produce salt and water –> increases gastric pH –> protects esophageal mucosa from reflex corrosion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 antacids and their AE

A

Aluminium hydroxide = constipation
Magnesium hydroxide = osmotic diarrhoea
—-> both combined to produce no change in bowel movements

Calcium carbonate = belching –> metabolic acidosis –> milk alkali syndrome –> renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What drugs cannot be given along with antacids?

A

Alter dissolution of weakly charged acids due to increased pH

Decreased absorption of co-administered tetracyclines, fluorquinolones, itraconazole and iron.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

H2 receptor antagonists MOA and drugs

A

Selective competitive inhibition at parietal cell H2 Gs coupled receptor

Suppress histamine inducing acid secretion –> Upstream blockade. Only partial suppression of acid production as the Ach and Gastrin pathways are still active.

Suppress basal gastric acid secretion but modest effect on meal stimulated secretion

1st gen = cimetidine
2nd gen = ranitidine, famotidine and nizatidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

H2RA AE

A

Tachyphlaxis develops in 2 to 6 weeks = repeated exposure to drug will cause down regulation of expression of H2 receptors and will lead to non-responsiveness

Cimetidine

  • Gynecomastia, galactorrhea and male impotence (Block androgen receptor and stimulates prolactin)
  • Crosses BBB: confusion, dizziness and headaches
  • B12 deficiency and myelosuppression in long-term use due to increased gastric pH (meat and animal products cannot be digested properly)
  • Inhibits CYP450: increased conc of drugs (warfarin, diazepam, phenytoin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

H2RA uses

A

GERD
PUD
Nonulcer dyspepsia
Prophylaxis against stress-related gastritis (burn and head-trauma patients)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PPIs drugs and MOA

A 
Omeprazole 
Esomeprazole 
Lansoprazole 
Rabeprazole 
Pantoprazole

Irreversibly inhibit H+/K+ ATPase proton pump in parental cells (final common pathway)–> inhibit 90-98% of 24 hours acid secretion

Suppress both basal and meal stimulated gastric acid production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PPIs uses

A

Patients who fail twice daily H2RA therapy

Severe GERD

PUD (H. pylori, NSAID associated) and prevention of peptic ulcer rebreeding

Nonulcer dyspepsia

Prophylaxis against stress-related gastritis (burn and head-trauma patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PPIs AE with long term use (4)

A

Vitamin B12 deficiency due to reduced pepsin function (due to increased pH)

Risk for community acquired pneumonias and C. difficile colitis

Hypomagnesemia

Osteopenia: reduced Ca2+ absorption or osteoclast inhibition –> increased risk of hip, spine, wrist fractures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PPIs drug interactions

A

Omeprazole = inhibit CYP450 enzymes (increased conc of drugs)

Omeprazole, Esomeprazole, Lansoprazole = inhibit CYP2C19 –> If clopidogrel is given with these drugs, it will not be activated as it is a prodrug

Pantoprazole or rabeprazol is preferred in people on clopidogrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why use PPIs for h. pylori eradication

A

1) direct antimicrobial properties
2) increased ph –> microbe will be actively dividing so antibiotics will be more effective –> lowers MIC of antibiotics needed to clear the organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Triple therapy for h. pylori eradication

A

Clarithromycin + amoxicillin + PPI

In penicillin allergic patients:
Clarithromycin + metronidazole + PPI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Quadruple therapy for h. pylori eradication

A

Bismuth subsalicylate + metronidazole + tetracycline + PPI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Misoprostol MOA

A

Analog of PGE1

Binds EP3 receptor –> stimulates Gi pathways to decrease gastric acid secretion

Stimulates mucus and bicarb secretion

Enhances mucosal blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Misoprostol uses

A

Prevention of NSAID-induced ulcers in high risk patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Misoprostol AE and contraindications

A

Diarrhea, abdominal pain, cramps

Contraindicated in pregnancy –> causes uterine contractions –> abortion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sucralfate MOA and use

A

Forms a viscous paste that binds selectively to ulcers –> neg charged sucrose sulphate binds pos charged proteins forming a physical barriers which stops further damage

Stimulated mucosal prostaglandin and bicarb secretion

Used for initial management of GERD in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Bismuth Subsalicylate MOA and uses

A

Suppresses H. pylori but no neutralisation action of acid

Used in quadruple therapy

Used for dyspepsia and acute diarrhea

20
Q

Bismuth Subsalicylate AE and contraindications

A

Bismuth toxicity rare

Metabolite bismuth sulfide causes harmless blackening of the stool

Can cause salicylate toxicity in combination with other salicylate products –> contraindicated in renal failure

21
Q

Prokinetic agents general MOA and drugs

A

Should enhance coordinated GI motility

Activating M1 receptors does not enhance coordinated contractions so drugs should act upstream of Ach at receptor sites on enteric neuron itself or higher

Erythromycin
Cisapride
Metoclopramide

22
Q

How is GI peristalsis regulated

A

1) Serotonin. Binds first and stimulates enteric neurons via 5-HT4 receptor–> which stimulate Ach via M1 to stimulate muscles –> More coordinated response of muscle contraction
2) Motilin binds directly to receptor on muscularis to stimulate contraction

23
Q

Erythromycin MOA and use

A

Macrolide antibiotic

Agonist effects the motion receptor

Rapid down-regulation of motion receptor –> early tolerance so only used for short courses

Used for diabetic gastroparesis

24
Q

Cisapride MOA and uses

A

5-HT4 receptor agonist, 5-HT3 antagonist and direct smooth muscle stimulant

No longer used as it is a pro-arrhythmic drug –> serious and fatal cardiac ventricular arrhythmias

25
Q

Metoclopramide MOA and uses

A

5-HT4 receptor agonist, vagal and central 5-HT3 antagonist and D2 receptor antagonist

Effects upper GI tract only:
Increased LES tone
Stimulates astral and small intestinal contractions

Uses:

  • Gastroparesis
  • Anti-emetic
26
Q

Metoclopramide AE

A

Extrapyramidal effects - due to dopamine antagonism (effects children and young adults)

Galactorrhea - block inhibitory effect of dopamine on prolactin –> increased prolactin release

27
Q

Chemotherapy induced N/V phases

A

Associated with some chemotherapeutic agents like cisplatin

Acute phase = universally experienced (within 24 hours)

Delayed phase = only affects some patients (on day 2-5)

28
Q

Prevention and treatment of motion sickness

A

Scopolamine (anticholinergic) as motion sickness is mediated by H1 and M receptors from inner ear to cerebellum

Not first line for CINV

29
Q

H1 antagonists used for motion sickness and post-operative emesis

A

Diphenhydramine, meclizine and cyclizine

Act on vestibular afferents and brainstem

30
Q

Ondansetron and granisetron MOA and uses

A

5-HT3 antagonists –> present in vagal afferents, the solitary tract nucleus, chemoreceptor trigger zone and area postrema

DOC for proxylaxis against immediate CINV

Also used for hyperemesis gravidarum in pregnancy

31
Q

NK1 antagonists and uses

A

Aprepitant - oral
Fosaprepitant - parenteral

Antagonist for NK1 receptor for substance P

Used for prophylaxis against delayed CINV

32
Q

Aprepitant metabolism

A

NK1 antagonist

Extensive CYP3A4 metabolism –> may affect metabolism of warfarin and OCP

33
Q

D2 antagonists drugs, use and AE

A

Promethazine
Droperidol

Antagonism at chemoreceptor trigger zone

Also has anti-histamine and anti-cholinergic effects = good for treating motion sickness

AE: extrapyramidal effects

34
Q

Dexamethasone
Methylprednisolone

MOA and uses

A

Corticosteriods.

Effective in treatment of nausea in patients with metastatic cancer => suppression of peritumoral inflammation and prostaglandin production

35
Q

Lorazepam
Alprazolam
Diazepam

Use as anti-emetics

MOA and AE

A

Benzos: No intrinsic anti-emetic effects

Useful adjuncts to do sedative, amnesic and anti-anxiety effects which reduce the anticipatory component of N/V

MOA: facilitate GABAa action in CNS by increasing Cl- channel opening

AE: CNS depression and dependence

36
Q

Dronabinol MOA and use as anti-emetics

A

Naturally occurring cannabinoid

Stimulates CB1 receptor in brainstem

Prophylaxis in patients receiving chemotherapy when other anti-emetic medications are not effective

37
Q

Dronabinol AE

A

Marijuana-like highs

CNS activity = palpitations, tachycardia, vasodilation, hypotension and bloodshot eyes

Paranoid reactions and thinking

Abrupt withdrawal => abstinence syndrome (irritability, insomnia, restlessness)

38
Q

Bulk-forming laxatives (3)

MOA

A

Methylcellulose
Psyllium
Bran

Non-digestable colloids –> absorb water to form bulky, soft jelly that distends the colon to promote peristalsis

39
Q

Contraindications of bulk-forming laxatives

A

Immobile patients
Patients on long-term opioid therapy

Can result in intestinal obstruction

40
Q

Cathartics (stimulant laxatives)

drugs, MOA and contraindications

A

Directly stimulate enteric nervous system to increase intestinal motility

Caster oil = broken down into ricinoleic acid in SI. Contraindicated in pregnancy as it causes uterine contractions.

Bisacodyl = acts at level of colon. Minimal systemic absorption –> can be used in acute and long-term.

Senna = chronic use can cause melanosis coli –> harmless brown pigmentation of colonic mucosa (unrelated to colon cancer risk)

41
Q

Stool softeners (2)

A

Docusate
Glycerin

Surfactants –> allow water to penetrate and soften formed stool in the bowel

42
Q

Lubricant laxative

A

Mineral oil = coats decal material and prevents water reabsorption

Cannot be given at the same times as stool softeners

43
Q

Osmotic laxatives (3)

A

MOA: non-absorbable sugars or salts –> exert osmotic pull to retain water in intestinal lumen

Lactulose - metabolised by colonic bacteria and can cause severe flatus with cramping

Magnesium salts - should not be used for long time in patients with renal insufficiency as thy can cause hypermagnesemia

Polyethylene glycol

  • water soluble
  • low toxicity and systemic absorption
  • creates very high osmotic pressures in gut lumen
  • used for total bowel prep before GI endoscopy
  • less AE, better for long term use
44
Q

Lubiprostone

A

Stimulates type 2 Cl- channels in SI –> increases Cl- secretion –> increased intestinal motility

Uses:

  • chronic constipation
  • IBS with predominant constipation

AE: diarrhea

Contraindicated in children

45
Q

Alvimopan

Methynaltrexone

A

Selective Mu-Opioid receptor antagonists

Use of opioid analgesics causes constipation due to stimulation of Mu receptors in bowel

Do not cross BBB –> do not negate analgesic effect of opioids

46
Q

Loperamide

Diphenoxylate

A

Low potential for addiction

Pharmacology (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions